Literature DB >> 15871994

Impact of EGFR expression on colorectal cancer patient prognosis and survival: a response.

L Repetto, W Gianni, A M Aglianò, P Gazzaniga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15871994     DOI： 10.1093/annonc/mdi263

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  8 in total

1.  Sulfiredoxin Promotes Colorectal Cancer Cell Invasion and Metastasis through a Novel Mechanism of Enhancing EGFR Signaling.

Authors:  Hong Jiang; Lisha Wu; Jing Chen; Murli Mishra; Hedy A Chawsheen; Haining Zhu; Qiou Wei
Journal:  Mol Cancer Res       Date:  2015-08-19       Impact factor: 5.852

2.  A linkage between effectual genes in progression of CRC through canonical and non-canonical TGF-β signaling pathways.

Authors:  Marzieh Shirin; Sajedeh Madadi; Noshad Peyravian; Zahra Pezeshkian; Leili Rejali; Masoumeh Hosseini; Afshin Moradi; Binazir Khanabadi; Ghazal Sherkat; Hamid Asadzadeh Aghdaei; Ehsan Nazemalhosseini-Mojarad
Journal:  Med Oncol       Date:  2022-01-29       Impact factor: 3.064

3.  In-vivo transfection of pcDNA3.1-IGFBP7 inhibits melanoma growth in mice through apoptosis induction and VEGF downexpression.

Authors:  Rong-Yi Chen; Hong-Xiang Chen; Jia-Xi Lin; Wei-Bing She; Ping Jiang; Li Xu; Ya-Ting Tu
Journal:  J Exp Clin Cancer Res       Date:  2010-02-16

4.  Aspirin Prevents Colorectal Cancer by Normalizing EGFR Expression.

Authors:  Haitao Li; Feng Zhu; Lisa A Boardman; Lei Wang; Naomi Oi; Kangdong Liu; Xiang Li; Yang Fu; Paul J Limburg; Ann M Bode; Zigang Dong
Journal:  EBioMedicine       Date:  2015-05-01       Impact factor: 8.143

5.  Low expression of chloride channel accessory 1 predicts a poor prognosis in colorectal cancer.

Authors:  Bo Yang; Lin Cao; Jiaen Liu; Yanjie Xu; Gillian Milne; Wanhei Chan; Steven D Heys; Colin D McCaig; Jin Pu
Journal:  Cancer       Date:  2015-01-20       Impact factor: 6.860

6.  AVL9 promotes colorectal carcinoma cell migration via regulating EGFR expression.

Authors:  Qiong Wu; Jing De Chen; Zhuqing Zhou
Journal:  Biol Proced Online       Date:  2022-01-06       Impact factor: 3.244

7.  Nimotuzumab enhances the sensitivity of non-small cell lung cancer cells to tumor necrosis factor-α by inhibiting the nuclear factor-кB signaling pathway.

Authors:  Jing Zhu; Ying Xin; Xiaoliang Liu; Ying Wang; Ying Liu
Journal:  Exp Ther Med       Date:  2018-02-12       Impact factor: 2.447

8.  An EGFR-targeting antibody-drug conjugate LR004-VC-MMAE: potential in esophageal squamous cell carcinoma and other malignancies.

Authors:  Xin-Yue Hu; Rong Wang; Jie Jin; Xiu-Jun Liu; A-Long Cui; Lian-Qi Sun; Yan-Ping Li; Yi Li; Yu-Cheng Wang; Yong-Su Zhen; Qing-Fang Miao; Zhuo-Rong Li
Journal:  Mol Oncol       Date:  2018-11-15       Impact factor: 6.603
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.